Skip to content

Effect of thyroid stimulating hormone level on early pregnancy outcome in normal pregnant women with normal thyroid function

Effect of thyroid stimulating hormone level on early pregnancy outcome in normal pregnant women with normal thyroid function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020098
Enrollment
Unknown
Registered
2018-12-14
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclinical hypothyroidism

Interventions

TSH 2.5~4.2mlU/L:Nil
TSH 0.27~2.5mlU/L:Nil

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: (1) Aged 20-38 years; (2) Natural pregnancy (including natural pregnancy, natural cycle FET, natural cycle IUI, etc.) and single pregnancy; (3) Thyroid-related hormones in serum were measured in 1 year before pregnancy. The results ranged from TSH 0.27 to 4.2 uIU/mL, FT4 12 to 22 pmol/L, TPO-Ab < 34 IU/mL, TG-Ab < 115 IU/mL; (4) Serum thyroid-related hormones (TSH, FT4, TPO-Ab, TG-Ab) were measured in the first Central Hospital of Tianjin in early pregnancy (gestational weeks < 8 weeks). The results ranged from TSH 0.27 to 4.2 uIU/mL, FT4.12 to 22 pmol/L, TPO-Ab < 34 IU/mL, TG-Ab < 115 IU/mL.

Exclusion criteria

Exclusion criteria: (1) Previous endocrine diseases such as thyroid disease, hypothalamus or pituitary gland, diabetes mellitus, hypertension, dyslipidemia, tuberculosis or cancer, polycystic ovary syndrome, acute and chronic hepatitis or autoimmune diseases; (2) Those with severe heart, lung, kidney and liver dysfunction, abnormal coagulation function, severe infectious diseases or poor general condition; (3) Endometriosis, hysteromyoma, adenomyosis, uterine malformation, severe pelvic adhesions and hydrosalpinx; (4) TORCH was positive for IgM in either spouse; (5) Exposure to radiation, heavy metals and poisons during pregnancy, or taking drugs that affect the fetus; (6) Recurrent abortion history.

Design outcomes

Primary

MeasureTime frame
abortion;

Secondary

MeasureTime frame
premature birth;low birth weight newborn;Neonatal asphyxia;Placental abruption;Gestational hypertension;

Countries

China

Contacts

Public ContactWang Yuanyuan

Tianjin First Central Hospital

w2001wyy@sina.com+86 13132060227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026